Back
TransDigm Group 10K Form
Sell
46
TDG
TransDigm Group
Last Price:
1,338.00
Seasonality Move:
12.24%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | TDG/TransDigm Group Quarterly |
2024-02-08 | 10Q | TDG/TransDigm Group Quarterly |
2023-08-08 | 10Q | TDG/TransDigm Group Quarterly |
2023-05-09 | 10Q | TDG/TransDigm Group Quarterly |
2023-02-07 | 10Q | TDG/TransDigm Group Quarterly |
2022-08-09 | 10Q | TDG/TransDigm Group Quarterly |
Receive TDG News And Ratings
See the #1 stock for the next 7 days that we like better than TDG
TDG Financial Statistics
Sales & Book Value
Annual Sales: | $6.59B |
---|---|
Cash Flow: | $568M |
Price / Cash Flow: | 43.52 |
Annual Sales: | $-44.90 |
Price / Book: | 0 |
Profitability
EPS (TTM): | 27.03000 |
---|---|
Net Income (TTM): | $1.66B |
Gross Margin: | $3.84B |
Return on Equity: | 0% |
Return on Assets: | 8.02% |
TransDigm Group Earnings Forecast
Key TransDigm Group Financial Ratios
- The Gross Profit Margin over the past 20 years for TDG is 58.34%.
- The Selling, General & Administrative Expenses for TDG have been equal to 11.69% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 89.68% of Operating Income.
- The Net Earning history of TDG is 19.71% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 14 years.
TransDigm Group Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Aerospace & Defense |
Sector: | Industrials |
Current Symbol: | TDG |
CUSIP: | 893641 |
Website: | transdigm.com |
Debt
Debt-to-Equity Ratio: | -8.69 |
---|---|
Current Ratio: | 3.81 |
Quick Ratio: | 2.52 |
Price-to-Earnings
Trailing P/E Ratio: | 60.72 |
---|---|
Forward P/E Ratio: | 29.62 |
TDG Technical Analysis vs Fundamental Analysis
Sell
46
TransDigm Group (TDG)
is a Sell
Is TransDigm Group a Buy or a Sell?
-
TransDigm Group stock is rated a Sell
The current TransDigm Group [TDG] share price is $1,337.60. The Score for TDG is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.